Table 5.
Parameters of the distribution of the CDLQI score at baseline and final visit and the observed change of the CDLQI score under therapy (baseline minus final visit) separated by gender for those patients with data at both visits − efficacy collective of adolescent patients
| Gender | Parameters of localization and dispersion of CDLQI score | |||||
|---|---|---|---|---|---|---|
| n | min | lower quartile | median | upper quartile | max | |
| Male | ||||||
| Baseline | 29 | 0.0 | 1.0 | 7.0 | 9.0 | 24.0 |
| Final visit | 29 | 0.0 | 1.0 | 3.0 | 6.0 | 18.0 |
| Change | 29 | −3.0 | 0.0 | 2.0 | 4.0 | 8.0 |
| Female | ||||||
| Baseline | 23 | 0.0 | 4.0 | 8.0 | 15.0 | 22.0 |
| Final visit | 23 | 0.0 | 2.0 | 4.0 | 9.0 | 22.0 |
| Change | 23 | −1.0 | 0.0 | 2.0 | 7.0 | 17.0 |
CDLQI, Children's Dermatology Life Quality Index; min, minimum; max, maximum.